SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
怡然乐萱sugar
Lv1
40 积分
2022-09-01 加入
最近求助
最近应助
互助留言
Long-term response to MEK inhibitor monotherapy in a patient with papillary thyroid carcinoma harboring BRAF V600E mutation
7天前
已完结
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
12天前
已完结
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer
12天前
已完结
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
22天前
已完结
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells
23天前
已完结
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review
23天前
已完结
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
23天前
已完结
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
1个月前
已完结
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies
1个月前
已完结
Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer
1个月前
已完结
没有进行任何应助
谢谢
4个月前
感谢
1年前
写错了【积分已退回】
1年前
找到了【积分已退回】
1年前
找到了【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论